SLXNW

Conviction 27HealthcareScan · Mon, Aug 10, 2026

SLXNW$0.0219+0.00%

ResistanceSupportVol 14

Vol MA14 105.21K

May 8May 27Jun 15Jul 2Jul 22Aug 7

Silexion Therapeutics CorpBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)silexion.com ↗

Price0.0219

Change+0.00%

Gap—

Rel volume0.00×

Avg volume73.87K

Avg $ vol3.5K

SMA 200.0187

SMA 500.0192

SMA 2000.0216

Price vs 50+13.93%

Price vs 200+1.20%

MA stackmixed

50/200 cross—

Supertrenddown · 0.0555

RSI (14)51

MACD hist-0.00

MACD crossbear · 4d

Stoch %K / %D24 / 16

ADX (14)25

+DI / −DI50 / 31

RSI divergence—

MACD divergence—

ATR %+91.77%

ADR %31.40%

52w high0.0500

52w low0.0000

From 52w high-56.20%

Above 52w low—

New 52w highNo

SqueezeOff

Bollinger width354.64%

%B0.55

Donchian pos24.33%

Donchian high0.0900

Donchian low0.0000

AVWAP (52w high)0.0527

vs AVWAP high-58.42%

AVWAP (52w low)0.0517

vs AVWAP low-57.64%

OBV trendUp

Chaikin MF (20)-0.40

Today vs 20d0.00×

Avg vol (14d)105.21K

Avg vol (20d)73.87K

Avg $ vol (20d)3.5K

Market cap91.76K

RS 3m (vs SPY)—

RS 6m (vs SPY)-50.45%

RS line new highNo

Trend template2/7

Technical rank36.3

1 week+9.50%

1 month-26.26%

3 months—

6 months-36.34%

1 year-27.24%

YTD-43.85%

P/E-0.01

P/B0.32

P/S—

P/FCF-0.01

EPS8.96

Div yield—

ROE—

ROA-258.84%

Debt/Eq—

Current1.00

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth27.89%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-2.32M

Revenue—

Net income-2.73M

Gross profit—

Free cash flow-10.83M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out5.94M

Employees13

ListedFri, Aug 16, 2024

Free float—

Float %—

Short interest5.73K

Days to cover15.0d

Short volume—

Squeeze score62 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction27 / 100

Pattern quality—

Tech rank36.3 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.0700

Support0.0000

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SLXNW

All disclosures →

No recent disclosed trades by Congress in SLXNW. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SLXNW

No recent insider (Form 4) filings in SLXNW. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in SLXNW

EDGAR →

No recent SEC filings on file for SLXNW.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.